Drum roll… In Vivo’s 2026 Rising Leaders were announced this week and included not one, not two, but five Optimum clients. A huge congratulations to Colleen Acosta of Freya Biosciences, Diana Čekatauskaitė of Lonza’s Synaffix, Reuben Dawkins of Link Biologics, Michelle Morrow of Nucleome Therapeutics, and Javier Nunez-Vicandi of Sofinnova Partners. This list recognises not […]
I spent 20 years as a print journalist and my first love will always be the written word. But you might have noticed we’ve switched our Hot Topic articles from being a purely written affair, to something that we deliver primarily by video. There’s a very simple reason for this. Video gets more views. Way […]
Easter may be over, but momentum across life sciences is building. Anglonordic Life Science Conference is less than two weeks away, alongside a steady stream of clinical progress, partnerships, and industry milestones, it’s all go! Our latest Optimum TV episode features Stephen Hansen of BioCentury and offers fresh insights into market trends and the Q2 […]
There’s now a good deal of observational data suggesting that GLP-1s do indeed cut the chance of developing obesity-related cancer – possibly by up to 40 per cent. But we all know that correlation and causation are not the same thing. So a group of Manchester University academics is planning to run a large study aimed at producing a definitive answer. They […]
Laigo Bio completed final close of oversubscribed €17 million seed financing Laigo Bio, a biotech company pioneering novel and highly differentiated therapies using its proprietary SureTACs™ precision membrane protein degradation platform, announced the successful completion of the second close of its seed financing round, securing an additional €5.5m, bringing the total raised to €17m. This […]
